Lupin is an innovation led Transnational Pharmaceutical Company producing developing and marketing a wide range of branded & generic formulations biotechnology products and active pharmaceutical ...
Indian pharmaceutical giant Lupin is scheduled to post its financial results for the second quarter (July-September) of fiscal year 2024-25 (Q2FY25) on Thursday, November 7. Brokerages expect Lupin to ...
It was another session of selloff at Dalal Street as Indian markets continued to bleed on Wednesday on the back rising inflation ... On the daily time frame, Lupin has broken down from a ...
The gentleman thief, Assane Diop, crept back into Paris and graced our Netflix screens again, serving a delicious feast of heists and hijinks. As the modern-day Arsène Lupin, Assane donned ...
Lupin has received tentative approval from the Food and Drug Administration for raltegravir tablets, 600 mg, which is a generic of Merck Sharp & Dohme’s Isentress HD tablets. Lupin is the ...